Bing-Wei Ye1,2,3, Chung-Kai Chou2,4, Yun-Cheng Hsieh1,2, Chung-Pin Li1,2, Yee Chao1,2, Ming-Chih Hou1,2,5, Han-Chieh Lin1,2, Kuei-Chuan Lee6,7. 1. Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. 2. Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. 3. Division of Gastroenterology, Department of Medicine, Taiwan Adventist Hospital, Taipei, Taiwan. 4. Division of Gastroenterology, Department of Medicine, National Yang-Ming University Hospital, Ilan, Taiwan. 5. Endoscopic Diagnosis and Therapeutic Center, Taipei Veterans General Hospital, Taipei, Taiwan. 6. Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. kclee2@vghtpe.gov.tw. 7. Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. kclee2@vghtpe.gov.tw.
Abstract
BACKGROUND AND AIMS: Self-expandable metallic stent insertion has been a mainstream treatment for relieving the obstructive symptoms of malignant gastric outlet obstruction (MGOO), a late-stage complication of gastrointestinal malignancies. This study aims to investigate the predictive value of stent expansion rates in clinical outcomes in patients with MGOO. METHODS: Eighty-seven patients with inoperable MGOO receiving metallic stents were reviewed retrospectively from April 2010 to December 2014. Clinical outcomes, predictors of stent patency, and survival were analyzed. RESULTS: The technical and clinical success rates were 100 and 94.3%, respectively. The median stent patency time was 114 days (range 13-570 days). The median survival time was 133 days (range 13-1145 days). Stent dysfunctions occurred in 28 patients (32.2%), with restenosis accounting for the majority (82%). The stent expansion rate ≥75% at Day 1 predicted the stent patency [hazard ratio (HR) 0.12, P = 0.04]. However, it did not correlate with survival. Non-gastric cancer origins (HR 2.41, P = 0.002) and peritoneal carcinomatosis (HR 2.54, P = 0.001) correlated with poor survival. However, post-stent chemotherapy (HR 0.55, P = 0.03) was related to better outcome. The comparison of clinical outcomes of first and second stent insertions showed no significant difference in the stent expansion rate either at Day 0 and Day 1 (P = 0.97 and P = 0.57). CONCLUSIONS: Self-expandable metallic stent insertion is a safe and effective treatment for relieving the obstructive symptoms. The stent expansion rate ≥75% at Day 1 is a novel stent-related predictor of stent patency.
BACKGROUND AND AIMS: Self-expandable metallic stent insertion has been a mainstream treatment for relieving the obstructive symptoms of malignant gastric outlet obstruction (MGOO), a late-stage complication of gastrointestinal malignancies. This study aims to investigate the predictive value of stent expansion rates in clinical outcomes in patients with MGOO. METHODS: Eighty-seven patients with inoperable MGOO receiving metallic stents were reviewed retrospectively from April 2010 to December 2014. Clinical outcomes, predictors of stent patency, and survival were analyzed. RESULTS: The technical and clinical success rates were 100 and 94.3%, respectively. The median stent patency time was 114 days (range 13-570 days). The median survival time was 133 days (range 13-1145 days). Stent dysfunctions occurred in 28 patients (32.2%), with restenosis accounting for the majority (82%). The stent expansion rate ≥75% at Day 1 predicted the stent patency [hazard ratio (HR) 0.12, P = 0.04]. However, it did not correlate with survival. Non-gastric cancer origins (HR 2.41, P = 0.002) and peritoneal carcinomatosis (HR 2.54, P = 0.001) correlated with poor survival. However, post-stent chemotherapy (HR 0.55, P = 0.03) was related to better outcome. The comparison of clinical outcomes of first and second stent insertions showed no significant difference in the stent expansion rate either at Day 0 and Day 1 (P = 0.97 and P = 0.57). CONCLUSIONS: Self-expandable metallic stent insertion is a safe and effective treatment for relieving the obstructive symptoms. The stent expansion rate ≥75% at Day 1 is a novel stent-related predictor of stent patency.
Authors: S Mehta; A Hindmarsh; E Cheong; J Cockburn; J Saada; R Tighe; M P N Lewis; M Rhodes Journal: Surg Endosc Date: 2005-12-09 Impact factor: 4.584
Authors: Seung Han Kim; Hoon Jai Chun; In Kyung Yoo; Jae Min Lee; Seung Joo Nam; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yeon Seok Seo; Yoon Tae Jeen; Hong Sik Lee; Soon Ho Um; Chang Duck Kim Journal: World J Gastroenterol Date: 2015-08-14 Impact factor: 5.742
Authors: Jorge M Canena; Ana C Lagos; Inês N Marques; Sara D Patrocínio; Miguel G Tomé; Manuel A Liberato; Carlos M Romão; António P Coutinho; Pedro M Veiga; Beatriz C Neves; Hélder D Além; José A Gonçalves Journal: Eur J Gastroenterol Hepatol Date: 2012-07 Impact factor: 2.566
Authors: Suzanne M Jeurnink; Ewout W Steyerberg; Jeanin E van Hooft; Casper H J van Eijck; Matthijs P Schwartz; Frank P Vleggaar; Ernst J Kuipers; Peter D Siersema Journal: Gastrointest Endosc Date: 2009-12-08 Impact factor: 9.427
Authors: Michael Piesman; Richard A Kozarek; John J Brandabur; Douglas K Pleskow; Ram Chuttani; Viktor E Eysselein; William B Silverman; John J Vargo; Irving Waxman; Marc F Catalano; Todd H Baron; Willis G Parsons; Adam Slivka; David L Carr-Locke Journal: Am J Gastroenterol Date: 2009-08-25 Impact factor: 10.864
Authors: Rajesh Krishnamoorthi; Shivanand Bomman; Petros Benias; Richard A Kozarek; Joyce A Peetermans; Edmund McMullen; Ornela Gjata; Shayan S Irani Journal: Endosc Int Open Date: 2022-06-10
Authors: Jin Won Mo; Young Min Kim; Jie-Hyun Kim; Seung Yong Shin; Young Hoon Youn; Hyojin Park Journal: Medicine (Baltimore) Date: 2020-05-22 Impact factor: 1.817